596 related articles for article (PubMed ID: 21964054)
1. Cancer vaccines and carbohydrate epitopes.
Heimburg-Molinaro J; Lum M; Vijay G; Jain M; Almogren A; Rittenhouse-Olson K
Vaccine; 2011 Nov; 29(48):8802-26. PubMed ID: 21964054
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
Hakomori S
Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
[TBL] [Abstract][Full Text] [Related]
3. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.
Berois N; Pittini A; Osinaga E
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158915
[TBL] [Abstract][Full Text] [Related]
4. Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.
Qin Q; Yin Z; Wu X; Haas KM; Huang X
Biomaterials; 2016 Sep; 101():189-98. PubMed ID: 27294537
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate antigens as targets for active specific immunotherapy.
Ragupathi G
Cancer Immunol Immunother; 1996 Nov; 43(3):152-7. PubMed ID: 9001568
[TBL] [Abstract][Full Text] [Related]
6. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
Livingston PO; Hood C; Krug LM; Warren N; Kris MG; Brezicka T; Ragupathi G
Cancer Immunol Immunother; 2005 Oct; 54(10):1018-25. PubMed ID: 15926079
[TBL] [Abstract][Full Text] [Related]
7. Keyhole limpet hemocyanin conjugate vaccines against cancer: the Memorial Sloan Kettering experience.
Musselli C; Livingston PO; Ragupathi G
J Cancer Res Clin Oncol; 2001 Oct; 127 Suppl 2():R20-6. PubMed ID: 11768620
[TBL] [Abstract][Full Text] [Related]
8. Differentiation-dependent expression of sialyl stage-specific embryonic antigen-1 and I-antigens on human lymphoid cells and its implications for carbohydrate-mediated adhesion to vascular endothelium.
Ohmori K; Takada A; Yoneda T; Buma Y; Hirashima K; Tsuyuoka K; Hasegawa A; Kannagi R
Blood; 1993 Jan; 81(1):101-11. PubMed ID: 8093344
[TBL] [Abstract][Full Text] [Related]
9. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
Zhang K; Baeckström D; Brevinge H; Hansson GC
J Cell Biochem; 1996 Mar; 60(4):538-49. PubMed ID: 8707893
[TBL] [Abstract][Full Text] [Related]
10. Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines.
Qiu J; Luo P; Wasmund K; Steplewski Z; Kieber-Emmons T
Hybridoma; 1999 Feb; 18(1):103-12. PubMed ID: 10211797
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated carbohydrate antigens of MUC1 - Implication in cancer development.
Radziejewska I
Biomed Pharmacother; 2024 May; 174():116619. PubMed ID: 38643541
[TBL] [Abstract][Full Text] [Related]
12. Distinct sub-populations of carcinoma-associated MUC1 mucins as detected by the monoclonal antibody 9H8 and antibodies against the sialyl-Lewis a and sialyl-Lewis x epitopes in the circulation of breast-cancer patients.
Sikut R; Zhang K; Baeckström D; Hansson GC
Int J Cancer; 1996 May; 66(5):617-23. PubMed ID: 8647622
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.
Beckwith DM; Cudic M
Semin Immunol; 2020 Feb; 47():101389. PubMed ID: 31926647
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy.
Rashidijahanabad Z; Huang X
Semin Immunol; 2020 Feb; 47():101390. PubMed ID: 31982247
[TBL] [Abstract][Full Text] [Related]
15. Mucoepidermoid carcinoma-associated expression of MUC5AC, MUC5B and mucin-type carbohydrate antigen sialyl-Tn in the parotid gland.
Matse JH; Bharos WK; Veerman ECI; Bloemena E; Bolscher JGM
Arch Oral Biol; 2017 Oct; 82():121-126. PubMed ID: 28628803
[TBL] [Abstract][Full Text] [Related]
16. Cellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens (sialyl Le(a), sialyl Le(x), GD3 and GM2) better than soluble lysate cancer vaccine.
Ravindranath MH; Bauer PM; Amiri AA; Miri SM; Kelley MC; Jones RC; Morton DL
Anticancer Drugs; 1997 Mar; 8(3):217-24. PubMed ID: 9095325
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a membrane-bound and a secreted mucin-type glycoprotein carrying the carcinoma-associated sialyl-Lea epitope on distinct core proteins.
Baeckström D; Hansson GC; Nilsson O; Johansson C; Gendler SJ; Lindholm L
J Biol Chem; 1991 Nov; 266(32):21537-47. PubMed ID: 1718981
[TBL] [Abstract][Full Text] [Related]
18. The role of Globo H and SSEA-4 in the development and progression of cancer, and their potential as therapeutic targets.
Sigal DS; Hermel DJ; Hsu P; Pearce T
Future Oncol; 2022 Jan; 18(1):117-134. PubMed ID: 34734786
[TBL] [Abstract][Full Text] [Related]
19. Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines.
Feng D; Shaikh AS; Wang F
ACS Chem Biol; 2016 Apr; 11(4):850-63. PubMed ID: 26895482
[TBL] [Abstract][Full Text] [Related]
20. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
